Kliogest

Norethisterone acetate and estradiol, the active ingredients in Kliogest, are a combined oral contraceptive presented as a tablet for oral use. They prevent pregnancy and help regulate menstrual cycles in women of reproductive age by modulating hormonal pathways.

GNH USA supplies Kliogest as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets.

Kliogest, a combined oral contraceptive, is used in hormonal regulation of the reproductive system.

- Contraception: prevents ovulation and reduces the likelihood of pregnancy. - Menstrual cycle regulation: promotes regular, predictable menstrual bleeding. - Management of menstrual disorders: helps control irregular bleeding and associated symptoms.

Kliogest may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: discomfort or swelling. - Spotting or irregular bleeding: unscheduled vaginal bleeding. - Mood changes: irritability or emotional fluctuations.

Serious or Rare Side Effects: - Venous thromboembolism: deep vein thrombosis or pulmonary embolism. - Stroke or myocardial infarction: cerebrovascular or cardiac events. - Hepatic adenoma: benign liver tumor formation. - Severe allergic reaction: anaphylaxis or angioedema.

Before prescribing Kliogest, clinicians should consider several safety aspects.

- Contraindicated in pregnancy: product is classified as Category X and must not be used. - Avoid in women with a history of thromboembolic disorders: increased risk of clot formation. - Caution in hypertension: monitor blood pressure regularly. - Do not use in smokers over 35 years: higher cardiovascular risk. - Assess liver function: hepatic disease may alter drug metabolism. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Kliogest can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Antiepileptic enzyme inducers (e.g., carbamazepine, phenytoin): reduce hormonal levels. - Rifampin: decreases contraceptive effectiveness. - Griseofulvin: may lower hormone concentrations. - Certain antiretrovirals (e.g., efavirenz): diminish contraceptive efficacy.

Moderate Interactions (Monitor Closely): - Antifungal agents (e.g., ketoconazole): may increase hormone plasma levels. - Macrolide antibiotics (e.g., erythromycin): can raise plasma concentrations. - St. John’s Wort: may reduce contraceptive effectiveness.